Literature DB >> 3114193

Amplification of human immuno-deficiency virus production from a virus-producing cell line in culture at high cell density.

K Ikuta, H Imai, S Ueda, S Suehiro, N Yamamoto, S Kato.   

Abstract

The amount of infectious virus released into the culture fluid from human immunodeficiency virus (HIV)-producing MOLT-4 cells (MOLT-4/HIV HTLV-III) was measured as a function of the culture conditions and cell density. After 3 days, the daily yield of infectious virus per cell in the fluid of non-growing cells cultured at high cell density was about 15 times higher than the accumulated yield from growing cells cultured at low cell density. SDS-PAGE analysis also showed a similar difference in the amounts of major gag protein p24.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3114193

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  5 in total

1.  Inhibition of HIV-1 replication and syncytium formation by synthetic CD4 peptides.

Authors:  Y Hayashi; K Ikuta; N Fujii; K Ezawa; S Kato
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

2.  Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1.

Authors:  M Yunoki; K Maotani-Imai; H Kusuda; M Motoyama; S Miyake; H Imai; Y S Shin; S Kato; K Sano; C Morita
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  The budding of defective human immunodeficiency virus type 1 (HIV-1) particles from cell clones persistently infected with HIV-1.

Authors:  T Goto; K Ikuta; J J Zhang; C Morita; K Sano; M Komatsu; H Fujita; S Kato; M Nakai
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  Human immunodeficiency virus type 1 vif, vpr, and vpu mutants can produce persistently infected cells.

Authors:  Y Nishino; M Kishi; M Sumiya; K Ogawa; A Adachi; K Maotani-Imai; S Kato; K Hirai; K Ikuta
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  Defective human immunodeficiency virus (HIV) particles produced by cloned cells of HTLV-I-carrying MT-4 cells persistently infected with HIV.

Authors:  K Ikuta; C Morita; M Nakai; N Yamamoto; S Kato
Journal:  Jpn J Cancer Res       Date:  1988-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.